China Pharma Holdings Income Statement (2010-2025) | CPHI

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	2.36M	2.42M	1.98M	2.89M	1.60M	1.61M	1.97M	2.92M	1.96M	1.10M	1.80M	2.15M	1.37M	0.92M	1.10M	1.13M	1.14M	1.03M	0.76M	1.23M
Cost of Revenue (Quarter)	0.38M	2.34M	0.13M	0.54M	0.18M	1.84M	0.26M	-4.65M	1.78M	1.24M	0.21M	0.26M	1.66M	1.94M	1.62M	-4.69M	1.27M	0.10M	0.08M	4.01M
Gross Profit (Quarter)	0.27M	0.07M	-0.30M	0.30M	-0.17M	-0.23M	-0.14M	0.04M	0.18M	-0.15M	-0.23M	-0.08M	-0.29M	-1.02M	-0.52M	-0.16M	-0.14M	-0.09M	-0.06M	0.15M
Operating items
Research & Development (Quarter)	0.19M	0.05M	0.02M	0.05M	0.05M	0.02M	0.09M	0.03M	0.02M	0.02M	0.05M	0.15M	0.03M	0.16M	0.09M	547.00	0.03M	0.02M	0.04M	0.19M
Selling, General & Administrative (Quarter)	0.41M	0.33M	0.30M	0.61M	0.51M	0.27M	0.28M	0.83M	0.42M	0.11M	0.25M	0.69M	0.49M	0.09M	0.35M	0.86M	0.51M	0.44M	0.42M	1.08M
Other Operating Expenses (Quarter)	0.37M	0.44M	0.14M	0.29M	0.17M	0.26M	0.19M	0.35M	0.13M	0.17M	0.19M	0.27M	0.11M	0.12M	0.13M	0.18M	0.09M	0.10M	0.10M	0.08M
Operating Expenses (Quarter)	0.97M	0.82M	0.47M	0.95M	0.74M	0.55M	0.55M	1.21M	0.58M	0.31M	0.48M	1.11M	0.63M	0.38M	0.57M	1.04M	0.62M	0.57M	0.57M	1.35M
Operating Income (Quarter)	-0.70M	-0.75M	-0.76M	1.36M	-0.91M	-0.78M	-0.69M	1.41M	-0.40M	-0.46M	-0.71M	0.80M	-0.92M	-1.39M	-1.09M	-1.20M	-0.76M	-0.65M	-0.63M	-1.20M
EBIT (Quarter)	-0.70M	-0.75M	-0.76M	1.36M	-0.91M	-0.78M	-0.69M	1.41M	-0.40M	-0.46M	-0.71M	0.80M	-0.92M	-1.39M	-1.09M	-1.20M	-0.76M	-0.65M	-0.63M	-1.20M
Non-operating items
Interest & Investment Income (Quarter)	406.00	579.00	638.00	0.00M	0.01M	0.00M	0.00M	0.00M	948.00	942.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	422.00	294.00	213.00
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)	-0.07M	-0.07M	-0.06M	-0.33M	-0.12M	-0.11M	-0.10M	-0.10M	-0.08M	-0.14M	-0.06M	-0.05M	-0.04M	-0.05M	-0.03M	-0.03M	-0.03M	0.12M	-0.02M	-0.02M
Net income details
EBT (Quarter)	-0.77M	-0.82M	-0.83M	-0.98M	-1.03M	-0.89M	-0.79M	-1.26M	-0.48M	-0.59M	-0.78M	-1.23M	-0.96M	-1.44M	-1.12M	-1.22M	-0.79M	-0.53M	-0.65M	-1.22M
Tax Provisions (Quarter)
Profit After Tax (Quarter)	-0.77M	-0.82M	-0.83M	-0.98M	-1.03M	-0.89M	-0.79M	-1.26M	-0.48M	-0.59M	-0.78M	-1.23M	-0.96M	-1.44M	-1.12M	-1.22M	-0.79M	-0.53M	-0.65M	-1.20M
Income from Continuing Operations (Quarter)	-0.77M	-0.82M	-0.83M	-0.98M	-1.03M	-0.89M	-0.79M	-1.26M	-0.48M	-0.59M	-0.78M	-1.23M	-0.96M	-1.44M	-1.12M	-1.22M	-0.79M	-0.53M	-0.65M	-1.22M
Consolidated Net Income (Quarter)	-0.77M	-0.82M	-0.83M	-0.98M	-1.03M	-0.89M	-0.79M	-1.26M	-0.48M	-0.59M	-0.78M	-1.23M	-0.96M	-1.44M	-1.12M	-1.22M	-0.79M	-0.53M	-0.65M	-1.22M
Income towards Parent Company (Quarter)	-0.77M	-0.82M	-0.83M	-0.98M	-1.03M	-0.89M	-0.79M	-1.26M	-0.48M	-0.59M	-0.78M	-1.23M	-0.96M	-1.44M	-1.12M	-1.22M	-0.79M	-0.53M	-0.65M	-1.22M
Net Income towards Common Stockholders (Quarter)	-0.77M	-0.82M	-0.83M	-0.98M	-1.03M	-0.89M	-0.79M	-1.26M	-0.48M	-0.59M	-0.78M	-1.23M	-0.96M	-1.44M	-1.12M	-1.22M	-0.79M	-0.53M	-0.65M	-1.22M
Additional items
EPS (Basic) (Quarter)	-0.02	-0.02	-0.02	-0.69	-0.22	-0.18	-0.16	-3.22	-0.29	-0.35	-0.29	-0.02	-0.72	-0.89	-0.65	-0.46	-0.24	-0.16	-0.17	-0.17
EPS (Weighted Average and Diluted) (Quarter)											-0.29	-0.02	-0.72	-0.89	-0.65	-0.46	-0.24	-0.16	-0.17	-0.17
Shares Outstanding (Weighted Average) (Quarter)		45.58M		4.61M	4.74M	4.79M			1.62M	1.69M	2.08M	3.38M	1.33M	1.47M	1.73M	1.75M	3.26M	3.26M	3.47M	4.29M
EBITDA (Quarter)	-0.84M	-0.64M	-0.86M	-0.84M	-0.98M	-1.52M	-1.39M	-1.08M	-0.27M	-1.12M	-0.71M	-1.11M	-0.98M	-1.48M	-0.98M	-1.43M	-0.78M	-0.51M	-0.59M	-1.04M
Interest Expenses (Quarter)	0.00M	0.07M	0.00M	0.25M	0.02M	0.01M	0.10M	-0.24M	0.08M	0.14M	0.01M	-0.25M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Tax Rate (Quarter)

Research Tools

China Pharma Holdings Income Statement (2010-2025) | CPHI

Create an account

Sign In

Reset Password